Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide
March 20, 2017 - 2:34pm
Toward the end of trading Monday, the Dow traded down 0.01 percent to 20,912.59 while the NASDAQ declined 0.04 percent to 5,898.64. The S&P also fell, dropping 0.19 percent to 2,373.85.
Leading and Lagging Sectors
Monday afternoon, the non-cyclical consumer goods & services sector proved to be a source of strength for the market.
In trading on Monday, utilities shares fell 0.66 percent. Meanwhile, top losers in the sector included RGC Resources Inc. (NASDAQ: RGCO), down 5 percent, and Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), down 5 percent.
The Washington Companies proposed to acquire Dominion Diamond Corp (NYSE: DDC) for US$13.50 per share in cash.
Equities Trading UP
Esperion Therapeutics Inc (NASDAQ: ESPR) shares shot up 64 percent to $38.82 after the company reported ...Full story available on Benzinga.com
Continue reading this article »